Chemoinformaics analysis of Dipropyl trisulfide
| Molecular Weight | 182.379 | nRot | 6 |
| Heavy Atom Molecular Weight | 168.267 | nRig | 7 |
| Exact Molecular Weight | 182.026 | nRing | 0 |
| Solubility: LogS | -2.474 | nHRing | 0 |
| Solubility: LogP | 2.73 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 28.0551 |
| nHD | 0 | BPOL | 16.5049 |
| QED | 0.586 |
| Synth | 2.716 |
| Natural Product Likeliness | 1.761 |
| NR-PPAR-gamma | 0.968 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.932 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.443 |
| MDCK | 0.0000441 |
| BBB | 0.954 |
| PPB | 0.817257 |
| VDSS | 0.626 |
| FU | 0.229849 |
| CYP1A2-inh | 0.225 |
| CYP1A2-sub | 0.243 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.366 |
| CYP2c9-inh | 0.03 |
| CYP2c9-sub | 0.848 |
| CYP2d6-inh | 0.069 |
| CYP2d6-sub | 0.422 |
| CYP3a4-inh | 0.14 |
| CYP3a4-sub | 0.222 |
| CL | 9.17 |
| T12 | 0.732 |
| hERG | 0.014 |
| Ames | 0.019 |
| ROA | 0.014 |
| SkinSen | 0.925 |
| Carcinogencity | 0.727 |
| EI | 0.908 |
| Respiratory | 0.129 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.974447 |